Department of Advanced Spectroscopy and Imaging, Centre of Biomedical Research (CBMR), Lucknow, Uttar Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India
Auto-generated profile, based on publicly available information
Rimjhim Trivedi
Department of Advanced Spectroscopy and Imaging, Centre of Biomedical Research (CBMR), Lucknow, Uttar Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India
STR polymorphisms have proven to be extremely useful in population genetics studies and human identification. The fifteen analysed STR loci were tetra-nucleotide repeats: D5S818, FGA, D8S1179, D21S11, D7S820, CSF1PO, D3S1358, THO1, D13S317, D16S539, D2S1338, D19S433, vWA, TPOX, D18S51.
Blood samples were obtained by venipuncture from random individuals of the populations: Tanjore Kallar (101), Vanniyar (87), Pallar (33) and Paraiyar (21). DNA was isolated using standard phenol/chloroform procedure (1). The 13 tetranucleotide repeat loci and two pentanucleotide repeat loci were amplified using the PowerPlex® 16 system (Promega Corporation, Madison) according to manufacturer's recommendations (2). The amplified products were separated and detected using the ABI Prism™ 377 DNA Sequencer (PE Applied Biosystems, Foster City). The data were analyzed using DNATYPE program (3). The genotype frequencies of the 15 loci studied in the four endogamous Tamil populations are given in Tables 1–4. Statistical results for G-square test, exact test, observed and expected homozygosity are presented in Tables 5–8. The data are consistent with that generated on other studied Indian population groups (4–7).
Samples were collected randomly from different individuals of East District of Sikkim. Nepali (N = 110). Bhutia ( N = 75) and Lepcha (N = 48) in form of either blood or buccal swab as per cooperation of participent. Genomic DNA was extracted by using standard phenol/chloroform procedure (2). Quantitation of DNA was carried out using the Quantiblot kit (PE Applied Biosystems) and subsequent PCR amplification was performed using the Powerplex™ 16 multiplex System (Promega Coip, Madison, U.S.A.) The products were detected on a 5% denaturing polyacrylamide sequencing gel using the ABI Prism™ 377 DNA Sequencer (PE Applied Biosystems) and genotype classification was made by comparison with allelic ladders provided with the Powerplex™ 16 System.
Gestational Diabetes Mellitus (GDM) is an emerging maternal health problem with increasing incidences. The lack of complete understanding of its pathophysiological mechanisms and novel regulatory biomarkers makes early diagnosis difficult. High-throughput RNA sequencing and computational bioinformatics analyses were conducted to identify novel hub genes, and their regulatory mechanisms were validated through qRT-PCR, western blot, and siRNA-mediated knockdown studies. Intermediate metabolites and circulatory levels of amino acids in the serum of GDM patients and healthy controls were measured. Transcriptomic studies identified SNW1 as the most sensitive and specific biomarker, significantly up-regulated in GDM (fold change = 1.09; p < 0.001). Metabolomic studies indicated significantly elevated gluconeogenesis in GDM, evidenced by decreased levels of alanine and increased levels of pyruvate and glucose compared to controls. siRNA-mediated knockdown of SNW1 in PANC1 cells resulted in significant down-regulation of alanine aminotransferase (ALT/GPT) and insulin receptor substrate (IRS1), while glucose transporters (GLUT2/GLUT4) and insulin (INS) were significantly up-regulated at both mRNA and protein levels. This study identified SNW1 as a novel insulin-resistant gene that induces hyperglycemia by elevating gluconeogenesis and decreasing glucose uptake. SNW1 may be considered a potential therapeutic target with clinical utility for the management of GDM.